Now Reading: SCTIMST unveils indigenously developed Chitra Core coronary stent
-
01
SCTIMST unveils indigenously developed Chitra Core coronary stent
SCTIMST unveils indigenously developed Chitra Core coronary stent
Sree Chitra Tirunal Institute for Medical Sciences and Technology has unveiled Chitra Core, its first coronary stent, at a conference in New Delhi. The polymer-coated Everolimus drug-eluting stent uses a Cobalt-Chromium alloy…
The Story in Brief
Sree Chitra Tirunal Institute for Medical Sciences and Technology has unveiled Chitra Core, its first coronary stent, at a conference in New Delhi. The polymer-coated Everolimus drug-eluting stent uses a Cobalt-Chromium alloy and has 30-40% less metal than conventional stents, according to SCTIMST scientist N.N. Subhash. The institute says this may reduce vessel damage and complications such as restenosis and late-stage thrombosis.
SCTIMST developed the design and transferred the technology to Invasive Technologies Pvt Ltd under a 2024 agreement. The company received a Central Drugs Standard Control Organisation manufacturing licence in December 2025. A second product, the polymer-free Chitra TiN stent with a Titanium Nitride coating, is ready for pre-clinical testing before a planned global launch. Its regulatory approval could take considerable time.
The Indian Opinion
The easy story is that an indigenous stent has already solved the problems of current devices. That claim goes beyond the evidence. Chitra Core has secured a manufacturing licence, but its clinical performance will matter more than its lower metal content. Chitra TiN is still before pre-clinical evaluations and faces international testing. Doctors and patients should watch published trial results, complication rates and affordability, not awards or launch events. Will the devices show better outcomes in routine Indian hospitals?
Source: thehindu.com
This story was synthesised by AI from the source linked above.
